Download PDF
Z Gastroenterol 2006; 44(1): 39-42
DOI: 10.1055/s-2005-858567
Kasuistik

© Karl Demeter Verlag im Georg Thieme Verlag KG Stuttgart · New York

Hepatocellular Carcinoma Associated with Hereditary Hemochromatosis Occurring in Non-Cirrhotic Liver

Hepatozelluläres Karzinom in Verbindung mit hereditärer Hämochromatose bei einem Patienten ohne LeberzirrhoseS. von Delius1 , C. Lersch1 , E. Schulte-Frohlinde1 , F. Fend1 , M. Dobritz1 , R. M. Schmid1 , F. Eckel1
  • 1Departments of Internal Medicine II, Pathology and Radiology, Technical University of Munich, Klinikum rechts der Isar, Munich, Germany
Further Information

Publication History

Publication Date:
05 January 2006 (online)

Also available at
    Permissions and Reprints

Abstract

The occurrence of primary hepatocellular carcinoma (HCC) in patients with hereditary hemochromatosis (HH) is well known. Thereby, the development of liver cirrhosis seems to be a prerequisite. Whether or not a hepatic iron overload in the context of hereditary hemochromatosis is an independent risk factor for HCC remains unclear. To date there are only a few reports about HCC arising in non-cirrhotic livers in the presence of HH. We report the case of a 64-year-old man who presented to our outpatient clinic with HCC. Liver cirrhosis could be excluded. Detailed exploration of the patient’s history revealed that he had been treated by venesection for about 10 years up to 15 years ago. Subsequent investigations showed an elevated serum ferritin and transferrin saturation. The diagnosis of HH was confirmed by genetic testing, with homozygosity for the Cys282Tyr mutation. The patient received palliative chemotherapy and finally died 15 months after initial diagnosis of HCC.

Zusammenfassung

Das erhöhte Risiko für die Entstehung von hepatozellulären Karzinomen (HCC) bei Patienten mit hereditärer Hämochromatose (HH) ist weithin bekannt. Voraussetzung hierzu scheint das Vorliegen einer Leberzirrhose zu sein. Ob bei Patienten mit HH eine Eisenüberladung der Leber unabhängig von zirrhotischen Veränderungen bereits einen eigenen Risikofaktor für HCC darstellt, bleibt unklar. Bislang existieren nur wenige Fallberichte über HCC bei HH in nichtzirrhotischen Lebern. Wir berichten über einen 64-jährigen Mann, der sich zur Behandlung eines HCC in unserer onkologischen Tagesklinik vorstellte. Eine Leberzirrhose konnte ausgeschlossen werden. Eine ausführliche Anamnese erbrachte, dass er bis vor 15 Jahren über einen Zeitraum von etwa 10 Jahren mit Aderlässen behandelt worden war. Weiterführende Untersuchungen ergaben erhöhte Werte für Serum Ferritin und Transferrinsättigung. Die Diagnose einer HH konnte durch eine Genanalyse bestätigt werden. Der Patient wies eine Homozygotie für die Mutation in Position Cys282Tyr auf. Er wurde palliativ chemotherapiert und verstarb schließlich 15 Monate nach Diagnosestellung.

Key words

Hepatocellular carcinoma - hemochromatosis - liver cirrhosis - iron overload

Schlüsselwörter

Hepatozelluläres Karzinom - Hämochromatose - Leberzirrhose - Eisenüberladung

References

  • 1 Kew M C. Hepatocellular carcinoma with and without cirrhosis. A comparison in southern African blacks.  Gastroenterology. 1989;  44 136-139
    PubMedGoogle Scholar
  • 2 Kew M C, Popper H. Relationship between hepatocellular carcinoma and cirrhosis.  Semin Liver Dis. 1984;  44 136-146
    PubMedGoogle Scholar
  • 3 Cauza E, Peck-Radosavljevic M, Ulrich-Pur H. et al . Mutations of the HFE gene in patients with hepatocellular carcinoma.  Am J Gastroenterol. 2003;  44 442-447
    PubMedGoogle Scholar
  • 4 Niederau C, Fischer R, Sonnenberg A. et al . Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis.  N Engl J Med. 1985;  44 1256-1262
    PubMedGoogle Scholar
  • 5 Elmberg M, Hultcrantz R, Ekbom A. et al . Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives.  Gastroenterology. 2003;  44 1733-1741
    PubMedGoogle Scholar
  • 6 Hsing A W, McLaughlin J K, Olsen J H. et al . Cancer risk following primary hemochromatosis: a population-based cohort study in Denmark.  Int J Cancer. 1995;  44 160-162
    PubMedGoogle Scholar
  • 7 Feder J N, Gnirke A, Thomas W. et al . A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.  Nat Genet. 1996;  44 399-408
    PubMedGoogle Scholar
  • 8 Carella M, D’Ambrosio L, Totaro A. et al . Mutation analysis of the HLA-H gene in Italian hemochromatosis patients.  Am J Hum Genet. 1997;  44 828-832
    PubMedGoogle Scholar
  • 9 Nielsen P, Carpinteiro S, Fischer R. et al . Prevalence of the C282Y and H63D mutations in the HFE gene in patients with hereditary haemochromatosis and in control subjects from Northern Germany.  Br J Haematol. 1998;  44 842-845
    PubMedGoogle Scholar
  • 10 Merryweather-Clarke A T, Pointon J J, Shearman J D. et al . Global prevalence of putative haemochromatosis mutations.  J Med Genet. 1997;  44 275-278
    PubMedGoogle Scholar
  • 11 Pietrangelo A. Hereditary hemochromatosis - a new look at an old disease.  N Engl J Med. 2004;  44 2283-2297
    PubMedGoogle Scholar
  • 12 Beutler E, Felitti V, Gelbart T. et al . The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic.  Ann Intern Med. 2000;  44 329-337
    PubMedGoogle Scholar
  • 13 Koziol J A, Felitti V J, Beutler E. The effect of HFE genotypes on measurements of iron overload.  Ann Intern Med. 2002;  44 700-701
    PubMedGoogle Scholar
  • 14 Guyader D, Gandon Y, Deugnier Y. et al . Evaluation of computed tomography in the assessment of liver iron overload. A study of 46 cases of idiopathic hemochromatosis.  Gastroenterology. 1989;  44 737-743
    PubMedGoogle Scholar
  • 15 Niederau C, Strohmeyer G, Stremmel W. Epidemiology, clinical spectrum and prognosis of hemochromatosis.  Adv Exp Med Biol. 1994;  44 293-302
    PubMedGoogle Scholar
  • 16 Fargion S, Mandelli C, Piperno A. et al . Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis.  Hepatology. 1992;  44 655-659
    PubMedGoogle Scholar
  • 17 Niederau C, Fischer R, Purschel A. et al . Long-term survival in patients with hereditary hemochromatosis.  Gastroenterology. 1996;  44 1107-1119
    PubMedGoogle Scholar
  • 18 Blumberg R S, Chopra S, Ibrahim R. et al . Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirrhosis.  Gastroenterology. 1988;  44 1399-1402
    PubMedGoogle Scholar
  • 19 Llovet J M, Burroughs A, Bruix J. Hepatocellular carcinoma.  Lancet. 2003;  44 1907-1917
    PubMedGoogle Scholar
  • 20 Fracanzani A L, Conte D, Fraquelli M. et al . Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease.  Hepatology. 2001;  44 647-651
    PubMedGoogle Scholar
  • 21 Britto M R, Thomas L A, Balaratnam N. et al . Hepatocellular carcinoma arising in non-cirrhotic liver in genetic haemochromatosis.  Scand J Gastroenterol. 2000;  44 889-893
    PubMedGoogle Scholar
  • 22 Deugnier Y M, Guyader D, Crantock L. et al . Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases.  Gastroenterology. 1993;  44 228-234
    PubMedGoogle Scholar
  • 23 Goh J, Callagy G, McEntee G. et al . Hepatocellular carcinoma arising in the absence of cirrhosis in genetic haemochromatosis: three case reports and review of literature.  Eur J Gastroenterol Hepatol. 1999;  44 915-919
    PubMedGoogle Scholar
  • 24 Brage A, Tome S, Figueruela B. et al . Hepatoma in a 40-year old male with hereditary hemochromatosis in the absence of cirrhosis. Implications of molecular diagnosis.  Rev Esp Enferm Dig. 2002;  44 493-499
    PubMedGoogle Scholar
  • 25 Meneghini R. Iron homeostasis, oxidative stress, and DNA damage.  Free Radic Biol Med. 1997;  44 783-792
    PubMedGoogle Scholar
  • 26 Esterbauer H. Cytotoxicity and genotoxicity of lipid-oxidation products.  Am J Clin Nutr. 1993;  44 779-786
    PubMedGoogle Scholar
  • 27 Hann H W, Stahlhut M W, Hann C L. Effect of iron and desferoxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines.  Hepatology. 1990;  44 566-569
    PubMedGoogle Scholar
  • 28 Rothenberg B E, Voland J R. Beta2 knockout mice develop parenchymal iron overload: A putative role for class I genes of the major histocompatibility complex in iron metabolism.  Proc Natl Acad Sci USA. 1996;  44 1529-1534
    PubMedGoogle Scholar
  • 29 Chapoutot C, Esslimani M, Joomaye Z. et al . Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis.  Gut. 2000;  44 711-714
    PubMedGoogle Scholar
  • 30 Ganne-Carrie N, Christidis C, Chastang C. et al . Liver iron is predictive of death in alcoholic cirrhosis: A multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study.  Gut. 2000;  44 277-282
    PubMedGoogle Scholar
  • 31 Tavill A. Diagnosis and management of hemochromatosis.  Hepatology. 2001;  44 1321-1328
    PubMedGoogle Scholar
  • 32 Pleass H, Garden O J. Early diagnosis of hepatocellular carcinoma in hemochromatosis influences surgical management.  Scot Med J. 1998;  44 114-115
    PubMedGoogle Scholar
  • 33 Muting D, Kalk J F, Fischer R. et al . Spontaneous regression of oesophageal varices after long-term conservative treatment: Retrospective study in 20 patients with alcoholic liver cirrhosis, post-hepatitic cirrhosis and haemochromatosis with cirrhosis.  J Hepatol. 1990;  44 158-162
    PubMedGoogle Scholar
  • 34 Ioannou G N, Kowdley K V. Iron, HFE mutations, and hepatocellular carcinoma: is hepatic iron a carcinogen?.  Clin Gastroenterol Hepatol. 2003;  44 246-248
    PubMedGoogle Scholar
  • 35 Kowdley K V. Iron, hemochromatosis, and hepatocellular carcinoma.  Gastroenterology. 2004;  44 79-86
    PubMedGoogle Scholar

MD Stefan von Delius

Klinikum rechts der Isar, II. Medizinische Klinik, Station 2/10

Ismaninger Str. 15

81675 München

Germany

Phone: ++ 49/89/41 40-22 51

Fax: ++ 49/89/41 40-49 64

Email: stefan_ruckert@yahoo.de

      >